East Rutherford, New Jersey, July 8, 2024 /CNW/ — Cambrex today announced the expansion of its stability storage business, Q1 Scientific, which provides controlled-environment stability storage services to the pharmaceutical, medical device and life sciences industries. Q1 Scientific is Durham, North Carolina It is expected to be located by the end of 2024, with advanced storage capabilities, next to the existing Cambrex analytical facility.
new Durham The facility will initially feature seven ICH stability chambers covering a range of conditions including 2-8°C, 25°C/40%RH, 25°C/60%RH, 30°C/65%RH, 40°C/75%RH, as well as -20°C and ultra-low temperature (-70°C/-80°C) storage conditions. A planned Phase 2 expansion within the next 24 months will potentially increase the facility’s capacity to 20 chambers, providing 20,000 cubic feet of storage space when complete. The facility Research Triangle Park (RTP) Location North Carolina We offer same-day and next-day delivery across the United States.
Tom Loewald“We are looking to expand the scope of Q1 Scientific’s business,” said Cambrex’s CEO. Durham, North CarolinaStrengthening our ability to serve pharmaceutical companies worldwide North AmericaThis investment not only expands our reach but also leverages Q1 Scientific’s extensive expertise in the stability storage business.”
Q1 Scientific advances Durham Complementing existing facilities Waterford, IrelandLiège, BelgiumIt has a global presence with three locations covering both sides of the Atlantic.
Stephen DelaneyThe Q1 Scientific managing director added, “Operating from three global locations will be a great benefit to customers, who can expect faster turnaround times for sample returns and expanded temperature-controlled shipping options throughout the U.S. and Canada.” Europe“
Cambrex continues to expand its capabilities and capabilities across its North American and European networks to meet the growing demand for outsourced drug development and manufacturing services.
About Cambrex
Cambrex is a leading global contract development and manufacturing organization (CDMO) providing the development and manufacture of pharmaceutical substances across the drug lifecycle, as well as comprehensive analytical and IND enablement services.
With over 40 years of experience and a team of 2,000 professionals, we serve clients around the world. North America and EuropeCambrex offers a range of specialty drug substance technologies and capabilities including continuous flow, controlled substances, solid state science, materials characterization and high potency APIs.
About Cambrex Q1 Scientific
Q1 Scientific, a Cambrex company, is a leading provider of controlled-environment stability storage services to the pharmaceutical, medical device and life sciences industries. With a decade of expertise, Q1 Scientific safeguards critical breakthroughs and life-changing innovations in our state-of-the-art facilities. Ireland and BelgiumQ1 Scientific’s services enable companies to accelerate the delivery of new drugs to market while avoiding the expense of building and monitoring their own vaults. June 2022Q1 Scientific Acquired by Cambrex.
Logo – https://mma.prnewswire.com/media/2236065/Cambrex_logo.jpg
Logo – https://mma.prnewswire.com/media/1830431/Q1_Scientific_Cambrex_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/cambrex-to-expand-stability-storage-business-with-new-facility-in-durham-north-carolina-302190242.html
SOURCE Cambrex
View original content: http://www.newswire.ca/en/releases/archive/July2024/08/c0602.html
